Nan Sun

4.5k total citations
111 papers, 2.4k citations indexed

About

Nan Sun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Nan Sun has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 45 papers in Molecular Biology. Recurrent topics in Nan Sun's work include Cancer Immunotherapy and Biomarkers (28 papers), Ferroptosis and cancer prognosis (20 papers) and Lung Cancer Treatments and Mutations (20 papers). Nan Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), Ferroptosis and cancer prognosis (20 papers) and Lung Cancer Treatments and Mutations (20 papers). Nan Sun collaborates with scholars based in China, United States and United Kingdom. Nan Sun's co-authors include Jie He, Zhiliang Lu, Jianbing Huang, Sufei Zheng, Chengming Liu, Yuanyuan Lei, Yun Che, Shuangshuang Mao, Yuan Li and Ruochuan Zang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Nan Sun

101 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Sun China 28 1.3k 936 846 824 363 111 2.4k
Yoshihisa Tokumaru Japan 28 1.1k 0.8× 1.1k 1.1× 859 1.0× 714 0.9× 507 1.4× 91 2.2k
Jianjun He China 27 940 0.7× 837 0.9× 846 1.0× 433 0.5× 386 1.1× 86 2.2k
Masanori Oshi Japan 31 1.3k 1.0× 1.4k 1.5× 1.1k 1.2× 961 1.2× 640 1.8× 132 2.8k
Ricardo Costa United States 22 848 0.7× 1.1k 1.2× 540 0.6× 601 0.7× 268 0.7× 82 2.2k
Yutian Zou China 33 2.0k 1.6× 1.0k 1.1× 1.4k 1.6× 782 0.9× 397 1.1× 67 3.1k
Xin Hu China 27 1.3k 1.0× 967 1.0× 822 1.0× 406 0.5× 377 1.0× 96 2.5k
Andreas Pircher Austria 27 1.7k 1.3× 1.5k 1.6× 931 1.1× 855 1.0× 871 2.4× 103 3.4k
Carminia Maria Della Corte Italy 26 1.3k 1.0× 1.5k 1.6× 430 0.5× 716 0.9× 476 1.3× 78 2.6k
Qingxia Fan China 30 1.4k 1.1× 717 0.8× 996 1.2× 486 0.6× 157 0.4× 111 2.3k
Wantao Wu China 19 927 0.7× 830 0.9× 595 0.7× 635 0.8× 700 1.9× 44 2.3k

Countries citing papers authored by Nan Sun

Since Specialization
Citations

This map shows the geographic impact of Nan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Sun more than expected).

Fields of papers citing papers by Nan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Sun. The network helps show where Nan Sun may publish in the future.

Co-authorship network of co-authors of Nan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Sun. A scholar is included among the top collaborators of Nan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Sun. Nan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chaofan, Yingshuang Zhang, Linyuan Wang, et al.. (2025). Discovery and biological evaluation of carborane-containing derivatives as TEAD auto palmitoylation inhibitors. Bioorganic & Medicinal Chemistry Letters. 121. 130155–130155. 1 indexed citations
2.
Cai, Yan, Xiuwen Liang, Lingzhi Wang, et al.. (2025). Impaired NLRP3 inflammasome signaling diverts pyroptotic to apoptotic caspase activation in macrophages. Frontiers in Immunology. 16. 1631152–1631152.
3.
Shi, Zhenwei, Zhuo Wan, Nan Sun, et al.. (2025). Synergistic nano-vaccine strategy for comprehensive activation of adaptive and innate immunity against Staphylococcus aureus infection. Frontiers in Immunology. 16. 1665710–1665710.
4.
Cui, Xinyu, Dongyu Li, Patricia Wu, et al.. (2025). Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application. Cancer Letters. 613. 217491–217491. 9 indexed citations
5.
Wang, Zhanyu, Nan Sun, Jie He, Esther Redín, & Charles M. Rudin. (2025). Molecular Subtypes of Neuroendocrine Carcinoma: From Chaos to Consensus. Annual Review of Pathology Mechanisms of Disease. 21(1). 107–133. 1 indexed citations
6.
Li, Yaping, X. H. Niu, Ge Zhang, et al.. (2025). Anti-alcoholism drug disulfiram inhibits PANoptosis by blocking mitochondrial permeabilization in macrophages. Frontiers in Immunology. 16. 1726408–1726408.
7.
Sun, Nan, et al.. (2025). The grand biological universe: A comprehensive geometric construction of genome space. The Innovation. 6(8). 100937–100937.
8.
Zhao, Weihua, Chuanfeng Huang, Qi Luo, et al.. (2024). Development of preimplantation genetic testing for monogenic reference materials using next-generation sequencing. BMC Medical Genomics. 17(1). 1 indexed citations
9.
10.
Luo, Yuejun, Yuxin Yao, Peng Wu, et al.. (2023). Profile of treatment-related adverse events of PD-1 blockade-based therapies in advanced esophageal cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 183. 103922–103922. 2 indexed citations
11.
Liu, Chengming, Lu Yang, Haiyan Xu, et al.. (2022). Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Medicine. 20(1). 187–187. 55 indexed citations
12.
Liu, Chengming, Sufei Zheng, Zhanyu Wang, et al.. (2022). KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer. Cancer Communications. 42(9). 828–847. 99 indexed citations
13.
Zhang, Zhihui, Yuejun Luo, Chaoqi Zhang, et al.. (2021). An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer. Cancer Cell International. 21(1). 6 indexed citations
14.
Bie, Fenglong, Nan Sun, Ruochuan Zang, et al.. (2021). Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians. Clinical Epigenetics. 13(1). 229–229. 11 indexed citations
15.
Zhang, Chaoqi, Guochao Zhang, Nan Sun, et al.. (2020). Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma. EBioMedicine. 59. 102959–102959. 50 indexed citations
16.
Che, Yun, Zhiwen Luo, Chaoqi Zhang, et al.. (2020). Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma. International Immunopharmacology. 87. 106802–106802. 10 indexed citations
17.
Yan, Yuanqing, Nan Sun, Hong Wang, et al.. (2019). Whole Genome–Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non–Small-Cell Lung Cancer. Cancer Research. 79(7). 1549–1557. 15 indexed citations
18.
Zheng, Sufei, Zhiliang Lu, Chengming Liu, et al.. (2019). The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis. Frontiers in Oncology. 9. 1340–1340. 5 indexed citations
19.
Zhang, Liang, Chengliang Yang, Yue Leon Guo, et al.. (2014). Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice. Inflammation. 37(6). 2006–2012. 33 indexed citations
20.
Han, Na, et al.. (2010). Studies involving the microscopic identification of two plants in Asclepiadaceae: Streptocaulon griffithii and Streptocaulon juventas. 亚洲传统医药. 5(2). 49–55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihisa Tokumaru Breakdown of academic impact, for papers by Jianjun He Breakdown of academic impact, for papers by Masanori Oshi Breakdown of academic impact, for papers by Ricardo Costa Breakdown of academic impact, for papers by Yutian Zou Breakdown of academic impact, for papers by Xin Hu Breakdown of academic impact, for papers by Andreas Pircher Breakdown of academic impact, for papers by Carminia Maria Della Corte Breakdown of academic impact, for papers by Qingxia Fan Breakdown of academic impact, for papers by Wantao Wu
Rankless by CCL
2026